Adagrasib is a kind of drug that blocks the KRAS G12C protein. It’s used to treat a type of lung cancer called NSCLC, which is caused by these mutations. It zeros in on and stops the bad KRAS protein from working.
The drug is presented in the form of 200 mg tablets, with the prescribed dosage being 600 mg taken twice per day. You can take it with or without eating. Adagrasib comes in bottles, each with 180 tablets.
